SCHEMBL526443

SCHEMBL526443

CCC(CC)N(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pentane SCHEMBL9486642 0.84 TSHR (0.41)
SCHEMBL2201360 0.82 TDP1 (0.30)
SCHEMBL9046 0.79
SCHEMBL19397678 0.79
SCHEMBL359418 0.79
SCHEMBL9045 0.79
SCHEMBL10592247 0.79
SCHEMBL1081916 0.79
SCHEMBL21413650 0.79
SCHEMBL10592237 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 481 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727969-A2 METHODS FOR PROVIDING INTERCELLULAR COMMUNICATION Rethink64 Bionetworks PBC (US) 2026-04-22 EP claimed
WO-2025151073-A1 COMPOSITION AND NANOPARTICLE SUITABLE FOR USE IN THE DELIVERY OF A THERAPEUTIC AGENT AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2025-07-17 WO claimed
WO-2024259374-A2 METHODS FOR PROVIDING INTERCELLULAR COMMUNICATION RETHINK64 BIONETWORKS PBC (US) 2024-12-19 WO claimed
WO-2023096903-A1 COMPOSITIONS FOR PRODUCING CELLULOSE- RESILIN AND CELLULOSE-COLLAGEN FIBERS BOLT THREADS, INC. (US) 2023-06-01 WO claimed
WO-2023048674-A1 DEVELOPMENT OF GLUCURONOXYLAN-BASED BIOINK İZMİR YÜKSEK TEKNOLOJİ ENSTİTÜSÜ (TR) 2023-03-30 WO claimed
WO-2022058809-A1 MULTILAYER POLYMERIC MATRIX UNIVERSIDAD DE LOS ANDES (CO) 2022-03-24 WO claimed
WO-2022034607-A1 DIAGNOSIS OF COVID-19 EMPLOYING LAB-ON-CHIP TECHNOLOGY THEVASAHAYAM AROCKIADOSS (IN) 2022-02-17 WO claimed
EP-3724630-A1 SYSTEMS, DEVICES, AND METHODS FOR IMPROVED TISSUE TREATMENT Dignity Health (US) 2020-10-21 EP claimed
WO-2019118082-A1 SYSTEMS, DEVICES, AND METHODS FOR IMPROVED TISSUE TREATMENT DIGNITY HEALTH (US) 2019-06-20 WO claimed
EP-3485002-A1 PLATFORMS AND METHODS FOR OPTIMIZING HOST ANTIGEN PRESENTATION AND HOST ANTITUMOR AND ANTIPATHOGEN IMMUNITY Ohio State Innovation Foundation (US) 2019-05-22 EP claimed
EP-0527936-A1 PROSTHETIC INTERVERTEBRAL DISC. REGEN CORP (US) 1993-02-24 EP claimed
EP-0461201-A4 PROSTHETIC MENISCUS 1992-05-13 EP claimed
EP-0461201-A1 PROSTHETIC MENISCUS. REGEN CORP (US) 1991-12-18 EP claimed
WO-1991016867-A1 PROSTHETIC INTERVERTEBRAL DISC REGEN CORPORATION (US) 1991-11-14 WO claimed
WO-1990009769-A1 PROSTHETIC MENISCUS REGEN CORPORATION (US) 1990-09-07 WO claimed
EP-0081582-A4 COMPOSITION OF A NOVEL IMMUNOGEN FOR PROTECTION AGAINST DIARRHEAL DISEASE CAUSED BY ENTEROTOXIGENIC ESCHERICHIA COLI. UNIV ROCHESTER (US) 1983-10-26 EP claimed
EP-0081582-A1 COMPOSITION OF A NOVEL IMMUNOGEN FOR PROTECTION AGAINST DIARRHEAL DISEASE CAUSED BY ENTEROTOXIGENIC ESCHERICHIA COLI. UNIV ROCHESTER (US) 1983-06-22 EP claimed
WO-1983000018-A1 COMPOSITION OF A NOVEL IMMUNOGEN FOR PROTECTION AGAINST DIARRHEAL DISEASE CAUSED BY ENTEROTOXIGENIC ESCHERICHIA COLI KLIPSTEIN, FREDERICK, A. 1983-01-06 WO claimed
EP-0037394-A1 A DEVICE FOR REMOVAL OF SUBSTANCES FROM A LIQUID. GAMBRO LUNDIA AB (SE) 1981-10-14 EP claimed
WO-1980002805-A1 PROCESS FOR THE TREATING OF AND/OR REMOVAL OF SUBSTANCES FROM A LIQUID,ESPECIALLY WHOLE BLOOD,AND A DEVICE AND A MEMBRANE FOR THE REALIZATION OF SAID PROCESS GAMBRO AB 1980-12-24 WO claimed